Is Mukesh Babu Fin. overvalued or undervalued?
As of October 17, 2025, Mukesh Babu Fin. is considered very expensive and overvalued with a PE ratio of 24.80, low ROCE and ROE of 1.18% and 1.26%, and a year-to-date decline of 15.25%, despite a strong long-term return of 269.19%.
As of 17 October 2025, the valuation grade for Mukesh Babu Fin. has moved from expensive to very expensive, indicating a significant deterioration in its valuation outlook. The company is currently deemed overvalued. Key ratios include a PE ratio of 24.80, an EV to EBITDA of 59.37, and a Price to Book Value of 0.28, which suggest that the company's earnings and cash flow are being priced at a premium compared to its book value.In comparison to its peers, Mukesh Babu Fin. stands out with a PE ratio of 24.80, while Bajaj Finance has a much higher PE of 38.21, and Life Insurance, considered very attractive, has a PE of just 11.49. Additionally, the company's ROCE and ROE are notably low at 1.18% and 1.26%, respectively, which further supports the overvaluation narrative. Despite a strong long-term performance with a 10-year return of 269.19%, recent stock performance has lagged behind the Sensex, with a year-to-date decline of 15.25% compared to the Sensex's gain of 7.44%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
